Electromed, Inc. develops, manufactures, markets, and sells airway clearance therapy and related products in the United States and internationally. The company offers SmartVest airway clearance system that consists of an inflatable therapy garment, a programmable air pulse generator, and a patented single-hose that delivers air pulses from the generator to the garment to patients with compromised pulmonary function; and SmartVest SQL System that provides advanced generator programmability and an enhanced pause feature with save, lock, and restore functionality. It also provides single patient use SmartVest and SmartVest Wrap products for health care providers working in intensive care units; and Aerobika, an oscillating positive expiratory pressure device. The company offers its products primarily to home health care market for patients with chronic lung issues, including bronchiectasis, cystic fibrosis, and neuromuscular disease. Electromed, Inc. markets its products primarily to physicians and health care providers, as well as directly to patients. The company was founded in 1992 and is headquartered in New Prague, Minnesota.
Industry, Sector and Symbol
Industry Medical Devices
Sub-IndustryN/A
SectorMedical
Phone+1-952-7589299
Debt
Price-To-Earnings
Sales & Book Value
Annual SalesN/A
Profitability
Miscellaneous
Employees132
OptionableNot Optionable
Electromed (NYSEAMERICAN:ELMD) Frequently Asked Questions
What is Electromed's stock symbol?
Electromed trades on the New York Stock Exchange (NYSE)AMERICAN under the ticker symbol "ELMD."
How were Electromed's earnings last quarter?
Electromed, Inc. (NYSEAMERICAN:ELMD) issued its quarterly earnings results on Tuesday, February, 12th. The medical equipment provider reported $0.04 earnings per share for the quarter. The medical equipment provider had revenue of $8.01 million for the quarter. View Electromed's Earnings History.
When is Electromed's next earnings date?
Has Electromed been receiving favorable news coverage?
News headlines about ELMD stock have trended somewhat positive this week, according to InfoTrie Sentiment Analysis. The research group identifies positive and negative media coverage by analyzing more than six thousand blog and news sources in real time. The firm ranks coverage of publicly-traded companies on a scale of negative five to positive five, with scores nearest to five being the most favorable. Electromed earned a coverage optimism score of 1.6 on InfoTrie's scale. They also assigned news headlines about the medical equipment provider a news buzz of 10.0 out of 10, meaning that recent media coverage is extremely likely to have an effect on the company's share price in the near future.
Who are some of Electromed's key competitors?
Some companies that are related to Electromed include Hamilton Thorne (HTL), Titan Medical (TMD), REVA Medical (RVA), Protech Home Medical (PHM), Osprey Medical (OSP), Universal Biosensors (UBI), Resonance Health (RHT), EMvision Medical Devices (EMV), Anteo Diagnostics (ADO), GI Dynamics (GID), Aurora Spine (ASG), Myomo (MYO), Myomo (MYO), LBT Innovations (LBT) and Azure Healthcare (AZV).
Who are Electromed's key executives?
Electromed's management team includes the folowing people:
- Ms. Kathleen S. Skarvan, CEO, Pres & Director (Age 63)
- Mr. Jeremy T. Brock CPA, CFO, Principal Accounting Officer & Financial Controller (Age 40)
- Mr. John Kowalczyk, VP of Sales & Marketing
- Mr. William J. George J.D., Sec. (Age 70)
- Ms. Kathryn Thompson, VP of Reimbursement
Who are Electromed's major shareholders?
Electromed's stock is owned by a variety of of institutional and retail investors. Top institutional investors include Tocqueville Asset Management L.P. (5.26%), Dimensional Fund Advisors LP (2.15%), Quantum Capital Management (1.50%), Algert Global LLC (1.49%), Teton Advisors Inc. (1.44%) and Gabelli Funds LLC (1.14%). Company insiders that own Electromed stock include Red Oak Partners, Llc and Stephen H Craney. View Institutional Ownership Trends for Electromed.
Which major investors are selling Electromed stock?
Which major investors are buying Electromed stock?
ELMD stock was acquired by a variety of institutional investors in the last quarter, including Tocqueville Asset Management L.P., Quantum Capital Management, Gabelli Funds LLC, Dimensional Fund Advisors LP, Acadian Asset Management LLC, Teton Advisors Inc. and Northern Trust Corp. View Insider Buying and Selling for Electromed.
How do I buy shares of Electromed?
Shares of ELMD can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.
What is Electromed's stock price today?
One share of ELMD stock can currently be purchased for approximately $5.75.
How big of a company is Electromed?
Electromed has a market capitalization of $48.21 million. Electromed employs 132 workers across the globe.
What is Electromed's official website?
How can I contact Electromed?
Electromed's mailing address is 500 6th Ave NW, NEW PRAGUE, MN 56071-1134, United States. The medical equipment provider can be reached via phone at +1-952-7589299.
MarketBeat Community Rating for Electromed (NYSEAMERICAN ELMD)
MarketBeat's community ratings are surveys of what our community members think about Electromed and other stocks. Vote "Outperform" if you believe ELMD will outperform the S&P 500 over the long term. Vote "Underperform" if you believe ELMD will underperform the S&P 500 over the long term. You may vote once every thirty days.
